ASNB going to be a good one. ASNB - Love these

ASNB going to be a good one.

ASNB - Love these tidbits from the 10q out 2/13/13:

"Gross profit on product sales for the three months ended December 31, 2012 was $244,000, or 55.5% of product sales, compared with ($25,000), or (14.0%) of product sales, for the prior year period. The improvement in gross profit dollars and gross profit as a percentage of product sales is primarily due to continued improvement in our manufacturing cost structure and efficiencies in our manufacturing processes combined with the increase in product sales" 

"Product sales of our biomaterials for the three months ended December 31, 2012 were $440,000 as compared with $179,000 for the prior year period, an increase of $261,000, or 145.8%. The increase is due to the growth in sales from existing and new customers."

Maybe this is really starting to work for them:
"A drug-free, antimicrobial technology to eradicate Methicillin-resistant Staphylococcus aureus ("MRSA") clinical infections associated with medical devices. A proprietary manufacturing process is differentiated by an innovative methodology whereby an antimicrobial agent is incorporated during the synthesis of a resin, using the Company's advanced polymer technologies, which is suitable for molding into medical devices. These antimicrobial formulations are designed to possess a high degree of bacterial "kill."